D-0292-2021 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0292-2021 was initiated by Dr. Reddy's Laboratories, Inc. on Feb 26, 2021 and is designated Class II. Reason for recall: Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing. The recall status is terminated (terminated Feb 17, 2022). Affected quantity: 16,449 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 10, 2021
Initiation Date
Feb 26, 2021
Termination Date
Feb 17, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,449 bottles

Product description

Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE; Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540; NDC 43598-350-01.

Reason for recall

Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.

Distribution pattern

Nationwide in the USA

Code information

Batch # 1399851P1, Exp 02/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0292-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0292-2021. Report a data issue: hello@regdatalab.com.